3,7,8,2'-Tetrahydroxyflavone
3,7-Dihydroxyflavone
4'-Dimethylamino-7,8-dihydroxyflavone
7,3′-Dihydroxyflavone
7,8,2'-Trihydroxyflavone
7,8,3'-Trihydroxyflavone
7,8-Dihydroxyflavone
ABT-110
ALE-0540
AM7 (drug)
AMG-458
ANA-12
ANXA2
ASP-6294
ATC code L01
AVE-1642
AZD-6918
Abemaciclib
Acalabrutinib
Accelerated approval
Actifed
Adagrasib
Adipotide
Adrenomedullin
Adverse effect
Afatinib
Aflibercept
Agerafenib
Alacizumab pegol
Alectinib
Alemtuzumab
Allen & Hanburys
Alpelisib
Altiratinib
American Society of Health-System Pharmacists
Amitriptyline
Amivantamab
Amoxicillin/clavulanic acid
Amphiregulin
Amuvatinib
Anaplastic lymphoma kinase
Anatomical Therapeutic Chemical Classification System
Ancestim
Andrew Witty
Angiopoietin 1
Angiopoietin 2
Angiopoietin 3
Angiopoietin 4
Angiopoietin receptor
Anthracycline
Antineoplastic
Apatinib
Aprutumab
Aprutumab ixadotin
Aquafresh
Artemin
Asciminib
Atezolizumab
Atezolizumab/hyaluronidase
Aumolertinib
Avapritinib
Avelumab
Axatilimab
Axitinib
Axokine
BC Powder
BMS-754807
BMS-777607
BNN-20
BNN-27
BRAF (gene)
Baricitinib
Bcr-abl fusion protein
Becaplermin
Beclometasone
Beecham Group
Belantamab mafodotin
Bermekimab
Betacellulin
Bevacizumab
Bexsero
Binimetinib
Bioavailability
Biological half-life
Biotene
Blinatumomab
Block Drug
Boostrix
Bosutinib
Boxed warning
Brain-derived neurotrophic factor
Breast cancer
Brentuximab vedotin
Brigatinib
Bruton's tyrosine kinase
Bupropion
Burosumab
C-Met
CAS Registry Number
CD117
CD135
CD20
CD30
CD33
CD3 (immunology)
CD52
CDK inhibitor
CE-245677
CH-7057288
CSPG5
CYP2C19
CYP2C8
CYP3A
Cabozantinib
Caltrate
Canada v. GlaxoSmithKline Inc.
Cancer immunotherapy
Cancer stem cells
Canertinib
Capecitabine
Capmatinib
Catumaxomab
Cediranib
Cemiplimab
Cenegermin
Centrum (multivitamin)
Cerebrolysin
Ceritinib
Cervarix
Cetuximab
ChEBI
ChEMBL
ChapStick
ChemSpider
Chemical formula
Chemotherapy
Chris Gent
Christopher v. SmithKline Beecham Corp.
Ciliary neurotrophic factor receptor
Cimetidine
Cixutumumab
Cobimetinib
Colony-stimulating factor
Combination therapy
CompTox Chemicals Dashboard
Connective tissue growth factor
Copanlisib
Cosibelimab
Crenolanib
Crizotinib
Cyclotraxin B
DMAQ-B1
DS-6051
Dabrafenib
Dacomitinib
DailyMed
Dalotuzumab
Dalpiciclib
Dapiclermin
Daratumumab
Dasatinib
Dehydroepiandrosterone
Dehydroepiandrosterone sulfate
Denileukin diftitox
Deoxygedunin
Depatuxizumab
Depatuxizumab mafodotin
Deprenyl
Des(1-3)IGF-1
Dexamethasone
Diarrhea
Dihexa
Dinutuximab beta
Diosmetin
Doi (identifier)
Dostarlimab
Drug-induced QT prolongation
DrugBank
Drug Industry Documents Archive
Drug metabolism
Drug nomenclature
Drugs.com
Duligotumab
Durvalumab
Dusigitumab
Duvelisib
EFNA1
EFNA2
EFNA3
EFNA4
EFNA5
EFNB1
EFNB2
EFNB3
EML4
EVT-901
Edrecolomab
Elotuzumab
Elranatamab
Emergen-C
Emibetuzumab
Emma Walmsley
Encorafenib
Enfortumab vedotin
Engerix-B
Eno (drug)
Entrectinib
Enzyme inhibitor
EpCAM
Epcoritamab
Ephrin
Epidermal growth factor
Epidermal growth factor receptor
Epigen
Epiregulin
ErbB
Erdafitinib
Erlotinib
Ersofermin
Ertumaxomab
Erythropoietin
Everolimus
Evinacumab
Excedrin (brand)
Excretion
Exotoxin
FDA
FGF1
FGF10
FGF15/19
FGF17
FGF18
FGF19
FGF2
FGF20
FGF22
FGF23
FGF3
FGF4
FGF5
FGF6
FGF7
FGF8
FGF9
FX007
Fasinumab
Fatigue (medical)
Feces
Fedratinib
Fibroblast growth factor
Fibroblast growth factor receptor
Fibroblast growth factor receptor 1
Fibroblast growth factor receptor 2
Fibroblast growth factor receptor 3
Fibroblast growth factor receptor 4
Ficlatuzumab
Figitumumab
Filgotinib
Flanvotumab
FluLaval
Fluarix
Fluticasone/salmeterol
Fluticasone propionate
Food and Drug Administration
Foretinib
Fosgonimeton
Frunevetmab
Fruquintinib
Fulranumab
Fusion protein
Futibatinib
Futuximab
GBR-900
GFRα1
GFRα2
GFRα3
GFRα4
GSK plc
GZ-389988
Gambogic amide
Ganitumab
Gefitinib
Gemtuzumab ozogamicin
Geritol
Gilteritinib
Glasdegib
GlaxoSmithKline
GlaxoSmithKline Pakistan
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Prize
GlaxoSmithKline Services Unlimited v Commission
Glia maturation factor
Glial cell line-derived neurotrophic factor
Glofitamab
Glucose-6-phosphate isomerase
Glypromate
Golvatinib
Goody's Powder
Gossypetin
Grandinin
Growth factor receptor
Guide to Pharmacology
H5N1 vaccine
HER2
HER2/neu
HER3
HER4
HIOC
Haleon
Havrix
Hedgehog signaling pathway
Henry Wellcome
Heparin-binding EGF-like growth factor
Hepatitis A and B vaccine
Hepatocyte growth factor
Hepatocyte growth factor receptor
Hepatoma-derived growth factor
Hepatyrix
Hiberix
Horlicks
Human Genome Sciences
IGF-1 LR3
IGFBP1
IGFBP2
IGFBP3
IGFBP4
IGFBP5
IGFBP6
IGFBP7
INCB28060
IUPAC nomenclature of chemistry
Ibandronic acid
Ibritumomab tiuxetan
Ibrutinib
Icotinib
Icrucumab
Idelalisib
Imatinib
Imgatuzumab
Inavolisib
Indication (medicine)
Infanrix
Infigratinib
Inotuzumab ozogamicin
Insulin
Insulin-like growth factor-binding protein
Insulin-like growth factor 1
Insulin-like growth factor 1 receptor
Insulin-like growth factor 2
Insulin-like growth factor 2 receptor
Interleukin
Interleukin 2
International Chemical Identifier
International Nonproprietary Name
Ipilimumab
Isatuximab
JNJ-38877605
JSmol
Janus kinase
John K. Smith
Judy Lewent
K252a
KEGG
KRAS
Keratinocyte growth factor
Kinase
Kinrix
LEVI-04
LM22A-4
Lamotrigine
Lapatinib (data page)
Larotrectinib
Laurie Glimcher
Lazertinib
Lenvatinib
Lestaurtinib
Letrozole
Leukemia
Leukemia inhibitory factor
Liatermin
Linsitinib
List of GSK plc products
Liver
Loncastuximab tesirine
Lorlatinib
Low-affinity nerve growth factor receptor
Lucozade
Lymphatic system
Lymphoma
Lynn Elsenhans
M. S. Banga
MEDI-578
MEN1
MK-2461
MTOR inhibitor
Macrophage-stimulating protein
Mahlon Kline
Masitinib
Matuzumab
Mecasermin
Mecasermin rinfabate
MedlinePlus
Menveo
Metastatic breast cancer
Midkine
Midostaurin
Migration-stimulating factor
Milciclib
Mirvetuximab soravtansine
Mitogen-activated protein kinase kinase
Mobocertinib
Mogamulizumab
Molar mass
Momelotinib
Monoclonal antibody therapy
Mosunetuzumab
Motesanib
Moxetumomab pasudotox
Mubritinib
Murodermin
Myeloid
N-Acetylserotonin
NRG2
NRG3
NRG4
NVP-ADW742
NVP-AEW541
Nausea
Naxitamab
Necitumumab
Nepidermin
Neratinib
Nerve growth factor
Nesvacumab
Neuregulin
Neuregulin-1
Neurotrophin-3
Neurotrophin-4
Neurturin
Nicoderm
Nicorette
Nilotinib
Nimotuzumab
Nintedanib
Niquitin
Nivolumab
Non-receptor tyrosine kinase
Norwogonin
Novartis
ONO-4474
ONO-5390556
OSl-906
Obinutuzumab
Odronextamab
Ofatumumab
Olaratumab
Olmutinib
Onartuzumab
Oncogene
Oncomodulin
Oportuzumab monatox
Oral administration
Orelabrutinib
Orlistat
Osimertinib
PDGFA
PDGFB
PDGFC
PDGFD
PF-04217903
PF-2341066
PHA-665752
PLX-7486
PMC (identifier)
PMID (identifier)
Pacritinib
Palbociclib
Palifermin
Pandemrix
Panitumumab
Parodontax
Paroxetine
Parsaclisib
Patrick Vallance
Patritumab
Pazopanib
Pediarix
Pegaptanib
Pembrolizumab
Pemigatinib
Persephin
Pertuzumab
Pexidartinib
Pharmacokinetics
Philip Hampton
Phosphorylation
Pi3K inhibitor
Piboserod
Pirtobrutinib
Pituitary adenylate cyclase-activating peptide